Chiasma: Chiasma Files Mycapssa European Application For Acromegaly
Chiasma Inc (NASDAQ: CHMA) submitted a marketing application to the European Medicines Agency seeking approval of Mycapssa (oral octreotide capsules) as maintenance therapy for adults with acromegaly. The application is supported ...Full story available on Benzinga.com
Read full article »
Chiasma is engaged in developing and commercializing novel oral formulations of therapies to treat chronic diseases.
Read more